Speed of response to platinum-based chemotherapy: Implications for the management of epithelial ovarian cancer
- 1 July 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (7) , 1071-1075
- https://doi.org/10.1016/0277-5379(87)90361-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Sequential chemotherapy for advanced epithelial ovarian cancer: Platinum combination cytoreduction followed by cyclophosphamide consolidationEuropean Journal of Cancer and Clinical Oncology, 1985
- “Second-effort” surgical resection for bulky ovarian cancerCancer, 1984
- Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatinCancer, 1984
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- 2ND-LOOK LAPAROTOMY IN THE MANAGEMENT OF EPITHELIAL OVARIAN-CARCINOMA - AN EVALUATION OF 50 CASES1984
- CYCLOPHOSPHAMIDE PLUS CIS-PLATINUM IN COMBINATION - TREATMENT PROGRAM FOR STAGE-III OR STAGE-IV OVARIAN-CARCINOMA1982
- Epithelial Carcinoma of the Ovary: Current StrategiesAnnals of Internal Medicine, 1981
- ADVANCED OVARIAN-CANCER - BRIEF INTENSIVE COMBINATION CHEMOTHERAPY AND 2ND-LOOK OPERATION1981
- MATHEMATIC MODEL FOR RELATING THE DRUG SENSITIVITY OF TUMORS TO THEIR SPONTANEOUS MUTATION-RATE1979